Researchers in Switzerland have engineered an artificial tissue in which human blood stem cells continue to function for several days.
This content was published on
2 minutes
swissinfo.ch/sb
The tissue, developed by scientists from the University of Basel, University Hospital Basel, and the Federal Institute of Technology, Zurich (ETHZ), mimics some of the complex biological properties of natural bone marrow niches.
Billions of blood cells are produced every day in human bone marrow. This constant supply is ensured by blood stem cells located in special niches within the marrow. These stem cells can multiply and mature into red and white blood cells, which then leave the bone marrow and enter the bloodstream.
For several years, researchers have been trying to reproduce natural bone marrow in the laboratory to better understand the mechanisms of blood formation and to develop new therapies – such as for the treatment of leukemia. However, this has proven to be extremely difficult because in conventional in vitro models the blood stem cells lose their ability to multiply and to differentiate into different types of blood cells.
The team now hope their new technique can be used to produce tailor-made solutions and further research possibilities.
“We could use bone and bone marrow cells from patients to create an in vitro model of blood diseases such as leukemia, for example. Importantly, we could do this in an environment that consists exclusively of human cells and which incorporates conditions tailored to the specific individual,” explains Professor Ivan Martin from the Department of Biomedicine at the University of Basel.
Swiss centre records over 200 victims of human trafficking
This content was published on
Last year 317 people took part in a protection programme run by the Specialist Unit for Trafficking in Women and Women’s Migration (FIZ) in German-speaking Switzerland.
This content was published on
The Geneva-based International Committee of the Red Cross (ICRC) and partners are opening a field hospital in southern Gaza on Tuesday.
Lack of smartphone sustainability in Switzerland hits environment
This content was published on
Almost half of all Swiss citizens hang on to their old smartphones, tablets and laptops, according to the Federal Statistical Office.
Police clear out pro-Palestinian students protesting in Geneva
This content was published on
The police intervened early on Tuesday to dislodge pro-Palestinian students who had been occupying the University of Geneva for almost a week.
New gel developed in Zurich renders alcohol harmless
This content was published on
A newly developed gel composed of whey proteins breaks down alcohol in the body and could reduce its harmful and intoxicating effects in humans.
Pro-Palestine protests extend to Basel and Fribourg universities
This content was published on
Demonstrators called for an academic boycott of all Israeli institutions and disassociation with Chaim Weizmann, the first Israeli president.
This content was published on
In many cases, China's use of AI undermines the national security of the US and its allies, according to a US government representative.
Swiss Hells Angels trial alleges rape and money laundering
This content was published on
An allegedly high-ranking member of the Hells Angels is accused of money laundering totalling millions and rape, among other serious crimes.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss researchers ‘grow’ cartilage from bone marrow stem cells
This content was published on
Under normal conditions the mesenchymal stem/stromal cells from the bone marrow of adults develop into cartilage tissue which then remodels into bone tissue. This is similar to what happens after a fracture, for example. However, the researchers found they could prevent embryonic cartilage from becoming bone tissue by inhibiting the signaling pathway of a specific…
Italian and Swedish researchers win richest Swiss science prize
This content was published on
The Louis-Jeantet Prize for Medicine has been awarded to Antonio Lanzavecchia from the Swiss-Italian University and Christer Betsholtz from the University of Uppsala in Sweden. They will each receive CHF700,000 ($728,221), of which CHF625,000 must be spent on research. Established in 1986, the prize recognises excellence in European biomedical research. The main fields covered include…
This content was published on
Nenad Ban of the federal technology institute ETH Zurich has been selected to receive the Otto Naegeli prize for his work on ribosomes.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.